Grand Pharmaceutical Group Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was HKD 10,529.59 million compared to HKD 9,562.29 million a year ago. Net income was HKD 1,880 million compared to HKD 2,079.42 million a year ago.

Basic earnings per share from continuing operations was HKD 0.536 compared to HKD 0.587 a year ago. Diluted earnings per share from continuing operations was HKD 0.536 compared to HKD 0.587 a year ago.